30/03/2023
Lyme disease is a growing threat across the US and rest of the world. Current estimations show there are half a million new cases in the US every year, with symptoms including fever, fatigue, joint and muscle pain, and a skin rash, all of which are common to a wide range of conditions.
When the well-known bullseye or target rash is not visible (it only appears in 70% of cases), the early diagnosis that is critical to effective treatment may be missed in as many as 3 out of 10 people.
Accurate and fast diagnosis is possible with Biocentaur's PrimeSpot which tests for a range of viruses including Lyme. If confirmed, the Biocentaur PaldiSpot test will pinpoint the strain of Lyme enabling the most suitable treatment plan to be created.
Head to https://biocentaur.com/clinicians/ to read more about our range of tests.